When the bacterium reproduces, so does the phage. Human phage therapy is hardly new. Before the discovery of penicillin, pioneering doctors around the world employed phages as healers, giving them ...

The global antibody discovery market size is anticipated to reach approximately USD 22,570 million by 2034, up from USD 9,570 ...

Phage therapy dates back to the early 20th century, shortly after the discovery of bacteriophages by English bacteriologist Frederick Twort (1915)[1] and French-Canadian Félix d'Hérelle (1917)[2] It ...

A. CARPB-expressing cells stained with nanobody-displaying phages. GFP signals mark cells expressing membrane-tethered CARPB. Nb.b201 phage, an irrelevant nanobody displaying phage, was used as ...

Although the advent and mass production of antibiotics caused a decline in phage therapy, the recent rise in antibiotic resistance has renewed the global interest in this line of treatment. In this ...

Mycobacteria are the world’s most deadly bacteria—causing infectious diseases including tuberculosis (TB), which alone kills ...

Bacteria, which are susceptible to infection by bacteriophages, often carry multiple genes encoding anti-phage defense ...

Researchers have produced the most detailed image to date of a bacteriophage -- phage for short -- that has allowed them to see for the first time the structural makeup of the part of the phage that ...

Phage display's power rests in the ability to ... McCafferty has also now founded antibody discovery and development company Iontas, also in Cambridge, UK, to capitalise on his approach.